Global Oral Anticoagulants Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
The Oral Anticoagulants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Oral Anticoagulants market size is estimated to be worth US$ 14950 million in 2021 and is forecast to a readjusted size of USD 23660 million by 2028 with a CAGR of 6.8% during review period. Deep Vein Thrombosis (DVT) accounting for % of the Oral Anticoagulants global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Direct Thrombin Inhibitors segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Oral Anticoagulants include Johnson & Johnson, Bristol-Myers Squibb, Boehringer Ingelheim, Sanofi, and Daiichi Sankyo, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Oral Anticoagulants market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe Oral Anticoagulants product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Anticoagulants, with price, sales, revenue and global market share of Oral Anticoagulants from 2019 to 2022.
Chapter 3, the Oral Anticoagulants competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Anticoagulants breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Oral Anticoagulants market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Anticoagulants.
Chapter 13, 14, and 15, to describe Oral Anticoagulants sales channel, distributors, customers, research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Oral Anticoagulants market size is estimated to be worth US$ 14950 million in 2021 and is forecast to a readjusted size of USD 23660 million by 2028 with a CAGR of 6.8% during review period. Deep Vein Thrombosis (DVT) accounting for % of the Oral Anticoagulants global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Direct Thrombin Inhibitors segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Oral Anticoagulants include Johnson & Johnson, Bristol-Myers Squibb, Boehringer Ingelheim, Sanofi, and Daiichi Sankyo, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Oral Anticoagulants market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Direct Thrombin Inhibitors
- Direct Factor Xa Inhibitors
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism
- Acute Coronary Syndrome
- Hemodialysis
- Others
- Johnson & Johnson
- Bristol-Myers Squibb
- Boehringer Ingelheim
- Sanofi
- Daiichi Sankyo
- Armatheon
- Aspen
- AstraZeneca
- Bayer
- Cellceutix
- Cosmo Pharmaceuticals
- CSL Behring
- Eisai
- GSK
- Marathon Pharmaceuticals
- Ockham Biotech
- Perosphere
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Oral Anticoagulants product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Anticoagulants, with price, sales, revenue and global market share of Oral Anticoagulants from 2019 to 2022.
Chapter 3, the Oral Anticoagulants competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Anticoagulants breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Oral Anticoagulants market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Anticoagulants.
Chapter 13, 14, and 15, to describe Oral Anticoagulants sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Oral Anticoagulants Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral Anticoagulants Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Direct Thrombin Inhibitors
1.2.3 Direct Factor Xa Inhibitors
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral Anticoagulants Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Deep Vein Thrombosis (DVT)
1.3.3 Pulmonary Embolism
1.3.4 Acute Coronary Syndrome
1.3.5 Hemodialysis
1.3.6 Others
1.4 Global Oral Anticoagulants Market Size & Forecast
1.4.1 Global Oral Anticoagulants Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Oral Anticoagulants Sales in Volume (2017-2028)
1.4.3 Global Oral Anticoagulants Price (2017-2028)
1.5 Global Oral Anticoagulants Production Capacity Analysis
1.5.1 Global Oral Anticoagulants Total Production Capacity (2017-2028)
1.5.2 Global Oral Anticoagulants Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oral Anticoagulants Market Drivers
1.6.2 Oral Anticoagulants Market Restraints
1.6.3 Oral Anticoagulants Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Oral Anticoagulants Product and Services
2.1.4 Johnson & Johnson Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bristol-Myers Squibb
2.2.1 Bristol-Myers Squibb Details
2.2.2 Bristol-Myers Squibb Major Business
2.2.3 Bristol-Myers Squibb Oral Anticoagulants Product and Services
2.2.4 Bristol-Myers Squibb Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Oral Anticoagulants Product and Services
2.3.4 Boehringer Ingelheim Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Oral Anticoagulants Product and Services
2.4.4 Sanofi Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Daiichi Sankyo
2.5.1 Daiichi Sankyo Details
2.5.2 Daiichi Sankyo Major Business
2.5.3 Daiichi Sankyo Oral Anticoagulants Product and Services
2.5.4 Daiichi Sankyo Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Armatheon
2.6.1 Armatheon Details
2.6.2 Armatheon Major Business
2.6.3 Armatheon Oral Anticoagulants Product and Services
2.6.4 Armatheon Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Aspen
2.7.1 Aspen Details
2.7.2 Aspen Major Business
2.7.3 Aspen Oral Anticoagulants Product and Services
2.7.4 Aspen Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Oral Anticoagulants Product and Services
2.8.4 AstraZeneca Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business
2.9.3 Bayer Oral Anticoagulants Product and Services
2.9.4 Bayer Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Cellceutix
2.10.1 Cellceutix Details
2.10.2 Cellceutix Major Business
2.10.3 Cellceutix Oral Anticoagulants Product and Services
2.10.4 Cellceutix Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Cosmo Pharmaceuticals
2.11.1 Cosmo Pharmaceuticals Details
2.11.2 Cosmo Pharmaceuticals Major Business
2.11.3 Cosmo Pharmaceuticals Oral Anticoagulants Product and Services
2.11.4 Cosmo Pharmaceuticals Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 CSL Behring
2.12.1 CSL Behring Details
2.12.2 CSL Behring Major Business
2.12.3 CSL Behring Oral Anticoagulants Product and Services
2.12.4 CSL Behring Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Eisai
2.13.1 Eisai Details
2.13.2 Eisai Major Business
2.13.3 Eisai Oral Anticoagulants Product and Services
2.13.4 Eisai Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 GSK
2.14.1 GSK Details
2.14.2 GSK Major Business
2.14.3 GSK Oral Anticoagulants Product and Services
2.14.4 GSK Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Marathon Pharmaceuticals
2.15.1 Marathon Pharmaceuticals Details
2.15.2 Marathon Pharmaceuticals Major Business
2.15.3 Marathon Pharmaceuticals Oral Anticoagulants Product and Services
2.15.4 Marathon Pharmaceuticals Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Ockham Biotech
2.16.1 Ockham Biotech Details
2.16.2 Ockham Biotech Major Business
2.16.3 Ockham Biotech Oral Anticoagulants Product and Services
2.16.4 Ockham Biotech Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Perosphere
2.17.1 Perosphere Details
2.17.2 Perosphere Major Business
2.17.3 Perosphere Oral Anticoagulants Product and Services
2.17.4 Perosphere Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 ORAL ANTICOAGULANTS BREAKDOWN DATA BY MANUFACTURER
3.1 Global Oral Anticoagulants Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Oral Anticoagulants Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Oral Anticoagulants
3.4 Market Concentration Rate
3.4.1 Top 3 Oral Anticoagulants Manufacturer Market Share in 2021
3.4.2 Top 6 Oral Anticoagulants Manufacturer Market Share in 2021
3.5 Global Oral Anticoagulants Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Oral Anticoagulants Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Oral Anticoagulants Market Size by Region
4.1.1 Global Oral Anticoagulants Sales in Volume by Region (2017-2028)
4.1.2 Global Oral Anticoagulants Revenue by Region (2017-2028)
4.2 North America Oral Anticoagulants Revenue (2017-2028)
4.3 Europe Oral Anticoagulants Revenue (2017-2028)
4.4 Asia-Pacific Oral Anticoagulants Revenue (2017-2028)
4.5 South America Oral Anticoagulants Revenue (2017-2028)
4.6 Middle East and Africa Oral Anticoagulants Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Oral Anticoagulants Sales in Volume by Type (2017-2028)
5.2 Global Oral Anticoagulants Revenue by Type (2017-2028)
5.3 Global Oral Anticoagulants Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Oral Anticoagulants Sales in Volume by Application (2017-2028)
6.2 Global Oral Anticoagulants Revenue by Application (2017-2028)
6.3 Global Oral Anticoagulants Price by Application (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America Oral Anticoagulants Sales by Type (2017-2028)
7.2 North America Oral Anticoagulants Sales by Application (2017-2028)
7.3 North America Oral Anticoagulants Market Size by Country
7.3.1 North America Oral Anticoagulants Sales in Volume by Country (2017-2028)
7.3.2 North America Oral Anticoagulants Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe Oral Anticoagulants Sales by Type (2017-2028)
8.2 Europe Oral Anticoagulants Sales by Application (2017-2028)
8.3 Europe Oral Anticoagulants Market Size by Country
8.3.1 Europe Oral Anticoagulants Sales in Volume by Country (2017-2028)
8.3.2 Europe Oral Anticoagulants Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific Oral Anticoagulants Sales by Type (2017-2028)
9.2 Asia-Pacific Oral Anticoagulants Sales by Application (2017-2028)
9.3 Asia-Pacific Oral Anticoagulants Market Size by Region
9.3.1 Asia-Pacific Oral Anticoagulants Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Oral Anticoagulants Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY APPLICATION
10.1 South America Oral Anticoagulants Sales by Type (2017-2028)
10.2 South America Oral Anticoagulants Sales by Application (2017-2028)
10.3 South America Oral Anticoagulants Market Size by Country
10.3.1 South America Oral Anticoagulants Sales in Volume by Country (2017-2028)
10.3.2 South America Oral Anticoagulants Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa Oral Anticoagulants Sales by Type (2017-2028)
11.2 Middle East & Africa Oral Anticoagulants Sales by Application (2017-2028)
11.3 Middle East & Africa Oral Anticoagulants Market Size by Country
11.3.1 Middle East & Africa Oral Anticoagulants Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Oral Anticoagulants Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of Oral Anticoagulants and Key Manufacturers
12.2 Manufacturing Costs Percentage of Oral Anticoagulants
12.3 Oral Anticoagulants Production Process
12.4 Oral Anticoagulants Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Oral Anticoagulants Typical Distributors
13.3 Oral Anticoagulants Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
1.1 Oral Anticoagulants Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral Anticoagulants Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Direct Thrombin Inhibitors
1.2.3 Direct Factor Xa Inhibitors
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral Anticoagulants Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Deep Vein Thrombosis (DVT)
1.3.3 Pulmonary Embolism
1.3.4 Acute Coronary Syndrome
1.3.5 Hemodialysis
1.3.6 Others
1.4 Global Oral Anticoagulants Market Size & Forecast
1.4.1 Global Oral Anticoagulants Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Oral Anticoagulants Sales in Volume (2017-2028)
1.4.3 Global Oral Anticoagulants Price (2017-2028)
1.5 Global Oral Anticoagulants Production Capacity Analysis
1.5.1 Global Oral Anticoagulants Total Production Capacity (2017-2028)
1.5.2 Global Oral Anticoagulants Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oral Anticoagulants Market Drivers
1.6.2 Oral Anticoagulants Market Restraints
1.6.3 Oral Anticoagulants Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Oral Anticoagulants Product and Services
2.1.4 Johnson & Johnson Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bristol-Myers Squibb
2.2.1 Bristol-Myers Squibb Details
2.2.2 Bristol-Myers Squibb Major Business
2.2.3 Bristol-Myers Squibb Oral Anticoagulants Product and Services
2.2.4 Bristol-Myers Squibb Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Oral Anticoagulants Product and Services
2.3.4 Boehringer Ingelheim Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Oral Anticoagulants Product and Services
2.4.4 Sanofi Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Daiichi Sankyo
2.5.1 Daiichi Sankyo Details
2.5.2 Daiichi Sankyo Major Business
2.5.3 Daiichi Sankyo Oral Anticoagulants Product and Services
2.5.4 Daiichi Sankyo Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Armatheon
2.6.1 Armatheon Details
2.6.2 Armatheon Major Business
2.6.3 Armatheon Oral Anticoagulants Product and Services
2.6.4 Armatheon Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Aspen
2.7.1 Aspen Details
2.7.2 Aspen Major Business
2.7.3 Aspen Oral Anticoagulants Product and Services
2.7.4 Aspen Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Oral Anticoagulants Product and Services
2.8.4 AstraZeneca Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business
2.9.3 Bayer Oral Anticoagulants Product and Services
2.9.4 Bayer Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Cellceutix
2.10.1 Cellceutix Details
2.10.2 Cellceutix Major Business
2.10.3 Cellceutix Oral Anticoagulants Product and Services
2.10.4 Cellceutix Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Cosmo Pharmaceuticals
2.11.1 Cosmo Pharmaceuticals Details
2.11.2 Cosmo Pharmaceuticals Major Business
2.11.3 Cosmo Pharmaceuticals Oral Anticoagulants Product and Services
2.11.4 Cosmo Pharmaceuticals Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 CSL Behring
2.12.1 CSL Behring Details
2.12.2 CSL Behring Major Business
2.12.3 CSL Behring Oral Anticoagulants Product and Services
2.12.4 CSL Behring Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Eisai
2.13.1 Eisai Details
2.13.2 Eisai Major Business
2.13.3 Eisai Oral Anticoagulants Product and Services
2.13.4 Eisai Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 GSK
2.14.1 GSK Details
2.14.2 GSK Major Business
2.14.3 GSK Oral Anticoagulants Product and Services
2.14.4 GSK Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Marathon Pharmaceuticals
2.15.1 Marathon Pharmaceuticals Details
2.15.2 Marathon Pharmaceuticals Major Business
2.15.3 Marathon Pharmaceuticals Oral Anticoagulants Product and Services
2.15.4 Marathon Pharmaceuticals Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Ockham Biotech
2.16.1 Ockham Biotech Details
2.16.2 Ockham Biotech Major Business
2.16.3 Ockham Biotech Oral Anticoagulants Product and Services
2.16.4 Ockham Biotech Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Perosphere
2.17.1 Perosphere Details
2.17.2 Perosphere Major Business
2.17.3 Perosphere Oral Anticoagulants Product and Services
2.17.4 Perosphere Oral Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 ORAL ANTICOAGULANTS BREAKDOWN DATA BY MANUFACTURER
3.1 Global Oral Anticoagulants Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Oral Anticoagulants Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Oral Anticoagulants
3.4 Market Concentration Rate
3.4.1 Top 3 Oral Anticoagulants Manufacturer Market Share in 2021
3.4.2 Top 6 Oral Anticoagulants Manufacturer Market Share in 2021
3.5 Global Oral Anticoagulants Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Oral Anticoagulants Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Oral Anticoagulants Market Size by Region
4.1.1 Global Oral Anticoagulants Sales in Volume by Region (2017-2028)
4.1.2 Global Oral Anticoagulants Revenue by Region (2017-2028)
4.2 North America Oral Anticoagulants Revenue (2017-2028)
4.3 Europe Oral Anticoagulants Revenue (2017-2028)
4.4 Asia-Pacific Oral Anticoagulants Revenue (2017-2028)
4.5 South America Oral Anticoagulants Revenue (2017-2028)
4.6 Middle East and Africa Oral Anticoagulants Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Oral Anticoagulants Sales in Volume by Type (2017-2028)
5.2 Global Oral Anticoagulants Revenue by Type (2017-2028)
5.3 Global Oral Anticoagulants Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Oral Anticoagulants Sales in Volume by Application (2017-2028)
6.2 Global Oral Anticoagulants Revenue by Application (2017-2028)
6.3 Global Oral Anticoagulants Price by Application (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America Oral Anticoagulants Sales by Type (2017-2028)
7.2 North America Oral Anticoagulants Sales by Application (2017-2028)
7.3 North America Oral Anticoagulants Market Size by Country
7.3.1 North America Oral Anticoagulants Sales in Volume by Country (2017-2028)
7.3.2 North America Oral Anticoagulants Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe Oral Anticoagulants Sales by Type (2017-2028)
8.2 Europe Oral Anticoagulants Sales by Application (2017-2028)
8.3 Europe Oral Anticoagulants Market Size by Country
8.3.1 Europe Oral Anticoagulants Sales in Volume by Country (2017-2028)
8.3.2 Europe Oral Anticoagulants Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific Oral Anticoagulants Sales by Type (2017-2028)
9.2 Asia-Pacific Oral Anticoagulants Sales by Application (2017-2028)
9.3 Asia-Pacific Oral Anticoagulants Market Size by Region
9.3.1 Asia-Pacific Oral Anticoagulants Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Oral Anticoagulants Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY APPLICATION
10.1 South America Oral Anticoagulants Sales by Type (2017-2028)
10.2 South America Oral Anticoagulants Sales by Application (2017-2028)
10.3 South America Oral Anticoagulants Market Size by Country
10.3.1 South America Oral Anticoagulants Sales in Volume by Country (2017-2028)
10.3.2 South America Oral Anticoagulants Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa Oral Anticoagulants Sales by Type (2017-2028)
11.2 Middle East & Africa Oral Anticoagulants Sales by Application (2017-2028)
11.3 Middle East & Africa Oral Anticoagulants Market Size by Country
11.3.1 Middle East & Africa Oral Anticoagulants Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Oral Anticoagulants Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of Oral Anticoagulants and Key Manufacturers
12.2 Manufacturing Costs Percentage of Oral Anticoagulants
12.3 Oral Anticoagulants Production Process
12.4 Oral Anticoagulants Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Oral Anticoagulants Typical Distributors
13.3 Oral Anticoagulants Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
LIST OF TABLES
Table 1. Global Oral Anticoagulants Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Oral Anticoagulants Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 4. Johnson & Johnson Major Business
Table 5. Johnson & Johnson Oral Anticoagulants Product and Services
Table 6. Johnson & Johnson Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 8. Bristol-Myers Squibb Major Business
Table 9. Bristol-Myers Squibb Oral Anticoagulants Product and Services
Table 10. Bristol-Myers Squibb Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 12. Boehringer Ingelheim Major Business
Table 13. Boehringer Ingelheim Oral Anticoagulants Product and Services
Table 14. Boehringer Ingelheim Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Sanofi Basic Information, Manufacturing Base and Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi Oral Anticoagulants Product and Services
Table 18. Sanofi Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 20. Daiichi Sankyo Major Business
Table 21. Daiichi Sankyo Oral Anticoagulants Product and Services
Table 22. Daiichi Sankyo Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Armatheon Basic Information, Manufacturing Base and Competitors
Table 24. Armatheon Major Business
Table 25. Armatheon Oral Anticoagulants Product and Services
Table 26. Armatheon Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Aspen Basic Information, Manufacturing Base and Competitors
Table 28. Aspen Major Business
Table 29. Aspen Oral Anticoagulants Product and Services
Table 30. Aspen Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 32. AstraZeneca Major Business
Table 33. AstraZeneca Oral Anticoagulants Product and Services
Table 34. AstraZeneca Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Bayer Basic Information, Manufacturing Base and Competitors
Table 36. Bayer Major Business
Table 37. Bayer Oral Anticoagulants Product and Services
Table 38. Bayer Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Cellceutix Basic Information, Manufacturing Base and Competitors
Table 40. Cellceutix Major Business
Table 41. Cellceutix Oral Anticoagulants Product and Services
Table 42. Cellceutix Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Cosmo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Cosmo Pharmaceuticals Major Business
Table 45. Cosmo Pharmaceuticals Oral Anticoagulants Product and Services
Table 46. Cosmo Pharmaceuticals Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 48. CSL Behring Major Business
Table 49. CSL Behring Oral Anticoagulants Product and Services
Table 50. CSL Behring Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Eisai Basic Information, Manufacturing Base and Competitors
Table 52. Eisai Major Business
Table 53. Eisai Oral Anticoagulants Product and Services
Table 54. Eisai Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. GSK Basic Information, Manufacturing Base and Competitors
Table 56. GSK Major Business
Table 57. GSK Oral Anticoagulants Product and Services
Table 58. GSK Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Marathon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Marathon Pharmaceuticals Major Business
Table 61. Marathon Pharmaceuticals Oral Anticoagulants Product and Services
Table 62. Marathon Pharmaceuticals Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Ockham Biotech Basic Information, Manufacturing Base and Competitors
Table 64. Ockham Biotech Major Business
Table 65. Ockham Biotech Oral Anticoagulants Product and Services
Table 66. Ockham Biotech Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Perosphere Basic Information, Manufacturing Base and Competitors
Table 68. Perosphere Major Business
Table 69. Perosphere Oral Anticoagulants Product and Services
Table 70. Perosphere Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Global Oral Anticoagulants Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 72. Global Oral Anticoagulants Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 73. Market Position of Manufacturers in Oral Anticoagulants, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 74. Global Oral Anticoagulants Production Capacity by Company, (K Units): 2020 VS 2021
Table 75. Head Office and Oral Anticoagulants Production Site of Key Manufacturer
Table 76. Oral Anticoagulants New Entrant and Capacity Expansion Plans
Table 77. Oral Anticoagulants Mergers & Acquisitions in the Past Five Years
Table 78. Global Oral Anticoagulants Sales by Region (2017-2022) & (K Units)
Table 79. Global Oral Anticoagulants Sales by Region (2023-2028) & (K Units)
Table 80. Global Oral Anticoagulants Revenue by Region (2017-2022) & (USD Million)
Table 81. Global Oral Anticoagulants Revenue by Region (2023-2028) & (USD Million)
Table 82. Global Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 83. Global Oral Anticoagulants Sales by Type (2023-2028) & (K Units)
Table 84. Global Oral Anticoagulants Revenue by Type (2017-2022) & (USD Million)
Table 85. Global Oral Anticoagulants Revenue by Type (2023-2028) & (USD Million)
Table 86. Global Oral Anticoagulants Price by Type (2017-2022) & (USD/Unit)
Table 87. Global Oral Anticoagulants Price by Type (2023-2028) & (USD/Unit)
Table 88. Global Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 89. Global Oral Anticoagulants Sales by Application (2023-2028) & (K Units)
Table 90. Global Oral Anticoagulants Revenue by Application (2017-2022) & (USD Million)
Table 91. Global Oral Anticoagulants Revenue by Application (2023-2028) & (USD Million)
Table 92. Global Oral Anticoagulants Price by Application (2017-2022) & (USD/Unit)
Table 93. Global Oral Anticoagulants Price by Application (2023-2028) & (USD/Unit)
Table 94. North America Oral Anticoagulants Sales by Country (2017-2022) & (K Units)
Table 95. North America Oral Anticoagulants Sales by Country (2023-2028) & (K Units)
Table 96. North America Oral Anticoagulants Revenue by Country (2017-2022) & (USD Million)
Table 97. North America Oral Anticoagulants Revenue by Country (2023-2028) & (USD Million)
Table 98. North America Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 99. North America Oral Anticoagulants Sales by Type (2023-2028) & (K Units)
Table 100. North America Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 101. North America Oral Anticoagulants Sales by Application (2023-2028) & (K Units)
Table 102. Europe Oral Anticoagulants Sales by Country (2017-2022) & (K Units)
Table 103. Europe Oral Anticoagulants Sales by Country (2023-2028) & (K Units)
Table 104. Europe Oral Anticoagulants Revenue by Country (2017-2022) & (USD Million)
Table 105. Europe Oral Anticoagulants Revenue by Country (2023-2028) & (USD Million)
Table 106. Europe Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 107. Europe Oral Anticoagulants Sales by Type (2023-2028) & (K Units)
Table 108. Europe Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 109. Europe Oral Anticoagulants Sales by Application (2023-2028) & (K Units)
Table 110. Asia-Pacific Oral Anticoagulants Sales by Region (2017-2022) & (K Units)
Table 111. Asia-Pacific Oral Anticoagulants Sales by Region (2023-2028) & (K Units)
Table 112. Asia-Pacific Oral Anticoagulants Revenue by Region (2017-2022) & (USD Million)
Table 113. Asia-Pacific Oral Anticoagulants Revenue by Region (2023-2028) & (USD Million)
Table 114. Asia-Pacific Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 115. Asia-Pacific Oral Anticoagulants Sales by Type (2023-2028) & (K Units)
Table 116. Asia-Pacific Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 117. Asia-Pacific Oral Anticoagulants Sales by Application (2023-2028) & (K Units)
Table 118. South America Oral Anticoagulants Sales by Country (2017-2022) & (K Units)
Table 119. South America Oral Anticoagulants Sales by Country (2023-2028) & (K Units)
Table 120. South America Oral Anticoagulants Revenue by Country (2017-2022) & (USD Million)
Table 121. South America Oral Anticoagulants Revenue by Country (2023-2028) & (USD Million)
Table 122. South America Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 123. South America Oral Anticoagulants Sales by Type (2023-2028) & (K Units)
Table 124. South America Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 125. South America Oral Anticoagulants Sales by Application (2023-2028) & (K Units)
Table 126. Middle East & Africa Oral Anticoagulants Sales by Region (2017-2022) & (K Units)
Table 127. Middle East & Africa Oral Anticoagulants Sales by Region (2023-2028) & (K Units)
Table 128. Middle East & Africa Oral Anticoagulants Revenue by Region (2017-2022) & (USD Million)
Table 129. Middle East & Africa Oral Anticoagulants Revenue by Region (2023-2028) & (USD Million)
Table 130. Middle East & Africa Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 131. Middle East & Africa Oral Anticoagulants Sales by Type (2023-2028) & (K Units)
Table 132. Middle East & Africa Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 133. Middle East & Africa Oral Anticoagulants Sales by Application (2023-2028) & (K Units)
Table 134. Oral Anticoagulants Raw Material
Table 135. Key Manufacturers of Oral Anticoagulants Raw Materials
Table 136. Direct Channel Pros & Cons
Table 137. Indirect Channel Pros & Cons
Table 138. Oral Anticoagulants Typical Distributors
Table 139. Oral Anticoagulants Typical Customers
Table 1. Global Oral Anticoagulants Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Oral Anticoagulants Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 4. Johnson & Johnson Major Business
Table 5. Johnson & Johnson Oral Anticoagulants Product and Services
Table 6. Johnson & Johnson Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 8. Bristol-Myers Squibb Major Business
Table 9. Bristol-Myers Squibb Oral Anticoagulants Product and Services
Table 10. Bristol-Myers Squibb Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 12. Boehringer Ingelheim Major Business
Table 13. Boehringer Ingelheim Oral Anticoagulants Product and Services
Table 14. Boehringer Ingelheim Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Sanofi Basic Information, Manufacturing Base and Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi Oral Anticoagulants Product and Services
Table 18. Sanofi Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 20. Daiichi Sankyo Major Business
Table 21. Daiichi Sankyo Oral Anticoagulants Product and Services
Table 22. Daiichi Sankyo Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Armatheon Basic Information, Manufacturing Base and Competitors
Table 24. Armatheon Major Business
Table 25. Armatheon Oral Anticoagulants Product and Services
Table 26. Armatheon Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Aspen Basic Information, Manufacturing Base and Competitors
Table 28. Aspen Major Business
Table 29. Aspen Oral Anticoagulants Product and Services
Table 30. Aspen Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 32. AstraZeneca Major Business
Table 33. AstraZeneca Oral Anticoagulants Product and Services
Table 34. AstraZeneca Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Bayer Basic Information, Manufacturing Base and Competitors
Table 36. Bayer Major Business
Table 37. Bayer Oral Anticoagulants Product and Services
Table 38. Bayer Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Cellceutix Basic Information, Manufacturing Base and Competitors
Table 40. Cellceutix Major Business
Table 41. Cellceutix Oral Anticoagulants Product and Services
Table 42. Cellceutix Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Cosmo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Cosmo Pharmaceuticals Major Business
Table 45. Cosmo Pharmaceuticals Oral Anticoagulants Product and Services
Table 46. Cosmo Pharmaceuticals Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 48. CSL Behring Major Business
Table 49. CSL Behring Oral Anticoagulants Product and Services
Table 50. CSL Behring Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Eisai Basic Information, Manufacturing Base and Competitors
Table 52. Eisai Major Business
Table 53. Eisai Oral Anticoagulants Product and Services
Table 54. Eisai Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. GSK Basic Information, Manufacturing Base and Competitors
Table 56. GSK Major Business
Table 57. GSK Oral Anticoagulants Product and Services
Table 58. GSK Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Marathon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Marathon Pharmaceuticals Major Business
Table 61. Marathon Pharmaceuticals Oral Anticoagulants Product and Services
Table 62. Marathon Pharmaceuticals Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Ockham Biotech Basic Information, Manufacturing Base and Competitors
Table 64. Ockham Biotech Major Business
Table 65. Ockham Biotech Oral Anticoagulants Product and Services
Table 66. Ockham Biotech Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Perosphere Basic Information, Manufacturing Base and Competitors
Table 68. Perosphere Major Business
Table 69. Perosphere Oral Anticoagulants Product and Services
Table 70. Perosphere Oral Anticoagulants Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Global Oral Anticoagulants Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 72. Global Oral Anticoagulants Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 73. Market Position of Manufacturers in Oral Anticoagulants, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 74. Global Oral Anticoagulants Production Capacity by Company, (K Units): 2020 VS 2021
Table 75. Head Office and Oral Anticoagulants Production Site of Key Manufacturer
Table 76. Oral Anticoagulants New Entrant and Capacity Expansion Plans
Table 77. Oral Anticoagulants Mergers & Acquisitions in the Past Five Years
Table 78. Global Oral Anticoagulants Sales by Region (2017-2022) & (K Units)
Table 79. Global Oral Anticoagulants Sales by Region (2023-2028) & (K Units)
Table 80. Global Oral Anticoagulants Revenue by Region (2017-2022) & (USD Million)
Table 81. Global Oral Anticoagulants Revenue by Region (2023-2028) & (USD Million)
Table 82. Global Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 83. Global Oral Anticoagulants Sales by Type (2023-2028) & (K Units)
Table 84. Global Oral Anticoagulants Revenue by Type (2017-2022) & (USD Million)
Table 85. Global Oral Anticoagulants Revenue by Type (2023-2028) & (USD Million)
Table 86. Global Oral Anticoagulants Price by Type (2017-2022) & (USD/Unit)
Table 87. Global Oral Anticoagulants Price by Type (2023-2028) & (USD/Unit)
Table 88. Global Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 89. Global Oral Anticoagulants Sales by Application (2023-2028) & (K Units)
Table 90. Global Oral Anticoagulants Revenue by Application (2017-2022) & (USD Million)
Table 91. Global Oral Anticoagulants Revenue by Application (2023-2028) & (USD Million)
Table 92. Global Oral Anticoagulants Price by Application (2017-2022) & (USD/Unit)
Table 93. Global Oral Anticoagulants Price by Application (2023-2028) & (USD/Unit)
Table 94. North America Oral Anticoagulants Sales by Country (2017-2022) & (K Units)
Table 95. North America Oral Anticoagulants Sales by Country (2023-2028) & (K Units)
Table 96. North America Oral Anticoagulants Revenue by Country (2017-2022) & (USD Million)
Table 97. North America Oral Anticoagulants Revenue by Country (2023-2028) & (USD Million)
Table 98. North America Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 99. North America Oral Anticoagulants Sales by Type (2023-2028) & (K Units)
Table 100. North America Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 101. North America Oral Anticoagulants Sales by Application (2023-2028) & (K Units)
Table 102. Europe Oral Anticoagulants Sales by Country (2017-2022) & (K Units)
Table 103. Europe Oral Anticoagulants Sales by Country (2023-2028) & (K Units)
Table 104. Europe Oral Anticoagulants Revenue by Country (2017-2022) & (USD Million)
Table 105. Europe Oral Anticoagulants Revenue by Country (2023-2028) & (USD Million)
Table 106. Europe Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 107. Europe Oral Anticoagulants Sales by Type (2023-2028) & (K Units)
Table 108. Europe Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 109. Europe Oral Anticoagulants Sales by Application (2023-2028) & (K Units)
Table 110. Asia-Pacific Oral Anticoagulants Sales by Region (2017-2022) & (K Units)
Table 111. Asia-Pacific Oral Anticoagulants Sales by Region (2023-2028) & (K Units)
Table 112. Asia-Pacific Oral Anticoagulants Revenue by Region (2017-2022) & (USD Million)
Table 113. Asia-Pacific Oral Anticoagulants Revenue by Region (2023-2028) & (USD Million)
Table 114. Asia-Pacific Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 115. Asia-Pacific Oral Anticoagulants Sales by Type (2023-2028) & (K Units)
Table 116. Asia-Pacific Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 117. Asia-Pacific Oral Anticoagulants Sales by Application (2023-2028) & (K Units)
Table 118. South America Oral Anticoagulants Sales by Country (2017-2022) & (K Units)
Table 119. South America Oral Anticoagulants Sales by Country (2023-2028) & (K Units)
Table 120. South America Oral Anticoagulants Revenue by Country (2017-2022) & (USD Million)
Table 121. South America Oral Anticoagulants Revenue by Country (2023-2028) & (USD Million)
Table 122. South America Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 123. South America Oral Anticoagulants Sales by Type (2023-2028) & (K Units)
Table 124. South America Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 125. South America Oral Anticoagulants Sales by Application (2023-2028) & (K Units)
Table 126. Middle East & Africa Oral Anticoagulants Sales by Region (2017-2022) & (K Units)
Table 127. Middle East & Africa Oral Anticoagulants Sales by Region (2023-2028) & (K Units)
Table 128. Middle East & Africa Oral Anticoagulants Revenue by Region (2017-2022) & (USD Million)
Table 129. Middle East & Africa Oral Anticoagulants Revenue by Region (2023-2028) & (USD Million)
Table 130. Middle East & Africa Oral Anticoagulants Sales by Type (2017-2022) & (K Units)
Table 131. Middle East & Africa Oral Anticoagulants Sales by Type (2023-2028) & (K Units)
Table 132. Middle East & Africa Oral Anticoagulants Sales by Application (2017-2022) & (K Units)
Table 133. Middle East & Africa Oral Anticoagulants Sales by Application (2023-2028) & (K Units)
Table 134. Oral Anticoagulants Raw Material
Table 135. Key Manufacturers of Oral Anticoagulants Raw Materials
Table 136. Direct Channel Pros & Cons
Table 137. Indirect Channel Pros & Cons
Table 138. Oral Anticoagulants Typical Distributors
Table 139. Oral Anticoagulants Typical Customers
LIST OF FIGURES
Figure 1. Oral Anticoagulants Picture
Figure 2. Global Oral Anticoagulants Revenue Market Share by Type in 2021
Figure 3. Direct Thrombin Inhibitors
Figure 4. Direct Factor Xa Inhibitors
Figure 5. Global Oral Anticoagulants Revenue Market Share by Application in 2021
Figure 6. Deep Vein Thrombosis (DVT)
Figure 7. Pulmonary Embolism
Figure 8. Acute Coronary Syndrome
Figure 9. Hemodialysis
Figure 10. Others
Figure 11. Global Oral Anticoagulants Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Oral Anticoagulants Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Oral Anticoagulants Sales (2017-2028) & (K Units)
Figure 14. Global Oral Anticoagulants Price (2017-2028) & (USD/Unit)
Figure 15. Global Oral Anticoagulants Production Capacity (2017-2028) & (K Units)
Figure 16. Global Oral Anticoagulants Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Oral Anticoagulants Market Drivers
Figure 18. Oral Anticoagulants Market Restraints
Figure 19. Oral Anticoagulants Market Trends
Figure 20. Global Oral Anticoagulants Sales Market Share by Manufacturer in 2021
Figure 21. Global Oral Anticoagulants Revenue Market Share by Manufacturer in 2021
Figure 22. Oral Anticoagulants Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Oral Anticoagulants Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Oral Anticoagulants Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Oral Anticoagulants Sales Market Share by Region (2017-2028)
Figure 26. Global Oral Anticoagulants Revenue Market Share by Region (2017-2028)
Figure 27. North America Oral Anticoagulants Revenue (2017-2028) & (USD Million)
Figure 28. Europe Oral Anticoagulants Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Oral Anticoagulants Revenue (2017-2028) & (USD Million)
Figure 30. South America Oral Anticoagulants Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Oral Anticoagulants Revenue (2017-2028) & (USD Million)
Figure 32. Global Oral Anticoagulants Sales Market Share by Type (2017-2028)
Figure 33. Global Oral Anticoagulants Revenue Market Share by Type (2017-2028)
Figure 34. Global Oral Anticoagulants Price by Type (2017-2028) & (USD/Unit)
Figure 35. Global Oral Anticoagulants Sales Market Share by Application (2017-2028)
Figure 36. Global Oral Anticoagulants Revenue Market Share by Application (2017-2028)
Figure 37. Global Oral Anticoagulants Price by Application (2017-2028) & (USD/Unit)
Figure 38. North America Oral Anticoagulants Sales Market Share by Type (2017-2028)
Figure 39. North America Oral Anticoagulants Sales Market Share by Application (2017-2028)
Figure 40. North America Oral Anticoagulants Sales Market Share by Country (2017-2028)
Figure 41. North America Oral Anticoagulants Revenue Market Share by Country (2017-2028)
Figure 42. United States Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Oral Anticoagulants Sales Market Share by Type (2017-2028)
Figure 46. Europe Oral Anticoagulants Sales Market Share by Application (2017-2028)
Figure 47. Europe Oral Anticoagulants Sales Market Share by Country (2017-2028)
Figure 48. Europe Oral Anticoagulants Revenue Market Share by Country (2017-2028)
Figure 49. Germany Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Oral Anticoagulants Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Oral Anticoagulants Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Oral Anticoagulants Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Oral Anticoagulants Revenue Market Share by Region (2017-2028)
Figure 58. China Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Oral Anticoagulants Sales Market Share by Type (2017-2028)
Figure 65. South America Oral Anticoagulants Sales Market Share by Application (2017-2028)
Figure 66. South America Oral Anticoagulants Sales Market Share by Country (2017-2028)
Figure 67. South America Oral Anticoagulants Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Oral Anticoagulants Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Oral Anticoagulants Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Oral Anticoagulants Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Oral Anticoagulants Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Oral Anticoagulants in 2021
Figure 79. Manufacturing Process Analysis of Oral Anticoagulants
Figure 80. Oral Anticoagulants Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Oral Anticoagulants Picture
Figure 2. Global Oral Anticoagulants Revenue Market Share by Type in 2021
Figure 3. Direct Thrombin Inhibitors
Figure 4. Direct Factor Xa Inhibitors
Figure 5. Global Oral Anticoagulants Revenue Market Share by Application in 2021
Figure 6. Deep Vein Thrombosis (DVT)
Figure 7. Pulmonary Embolism
Figure 8. Acute Coronary Syndrome
Figure 9. Hemodialysis
Figure 10. Others
Figure 11. Global Oral Anticoagulants Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Oral Anticoagulants Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Oral Anticoagulants Sales (2017-2028) & (K Units)
Figure 14. Global Oral Anticoagulants Price (2017-2028) & (USD/Unit)
Figure 15. Global Oral Anticoagulants Production Capacity (2017-2028) & (K Units)
Figure 16. Global Oral Anticoagulants Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Oral Anticoagulants Market Drivers
Figure 18. Oral Anticoagulants Market Restraints
Figure 19. Oral Anticoagulants Market Trends
Figure 20. Global Oral Anticoagulants Sales Market Share by Manufacturer in 2021
Figure 21. Global Oral Anticoagulants Revenue Market Share by Manufacturer in 2021
Figure 22. Oral Anticoagulants Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Oral Anticoagulants Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Oral Anticoagulants Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Oral Anticoagulants Sales Market Share by Region (2017-2028)
Figure 26. Global Oral Anticoagulants Revenue Market Share by Region (2017-2028)
Figure 27. North America Oral Anticoagulants Revenue (2017-2028) & (USD Million)
Figure 28. Europe Oral Anticoagulants Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Oral Anticoagulants Revenue (2017-2028) & (USD Million)
Figure 30. South America Oral Anticoagulants Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Oral Anticoagulants Revenue (2017-2028) & (USD Million)
Figure 32. Global Oral Anticoagulants Sales Market Share by Type (2017-2028)
Figure 33. Global Oral Anticoagulants Revenue Market Share by Type (2017-2028)
Figure 34. Global Oral Anticoagulants Price by Type (2017-2028) & (USD/Unit)
Figure 35. Global Oral Anticoagulants Sales Market Share by Application (2017-2028)
Figure 36. Global Oral Anticoagulants Revenue Market Share by Application (2017-2028)
Figure 37. Global Oral Anticoagulants Price by Application (2017-2028) & (USD/Unit)
Figure 38. North America Oral Anticoagulants Sales Market Share by Type (2017-2028)
Figure 39. North America Oral Anticoagulants Sales Market Share by Application (2017-2028)
Figure 40. North America Oral Anticoagulants Sales Market Share by Country (2017-2028)
Figure 41. North America Oral Anticoagulants Revenue Market Share by Country (2017-2028)
Figure 42. United States Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Oral Anticoagulants Sales Market Share by Type (2017-2028)
Figure 46. Europe Oral Anticoagulants Sales Market Share by Application (2017-2028)
Figure 47. Europe Oral Anticoagulants Sales Market Share by Country (2017-2028)
Figure 48. Europe Oral Anticoagulants Revenue Market Share by Country (2017-2028)
Figure 49. Germany Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Oral Anticoagulants Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Oral Anticoagulants Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Oral Anticoagulants Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Oral Anticoagulants Revenue Market Share by Region (2017-2028)
Figure 58. China Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Oral Anticoagulants Sales Market Share by Type (2017-2028)
Figure 65. South America Oral Anticoagulants Sales Market Share by Application (2017-2028)
Figure 66. South America Oral Anticoagulants Sales Market Share by Country (2017-2028)
Figure 67. South America Oral Anticoagulants Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Oral Anticoagulants Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Oral Anticoagulants Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Oral Anticoagulants Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Oral Anticoagulants Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Oral Anticoagulants Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Oral Anticoagulants in 2021
Figure 79. Manufacturing Process Analysis of Oral Anticoagulants
Figure 80. Oral Anticoagulants Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
